These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 9326220

  • 1. Use of alpha-2a-interferon to treat cytogenetic relapse of chronic myeloid leukemia after marrow transplantation.
    Higano CS, Chielens D, Raskind W, Bryant E, Flowers ME, Radich J, Clift R, Appelbaum F.
    Blood; 1997 Oct 01; 90(7):2549-54. PubMed ID: 9326220
    [Abstract] [Full Text] [Related]

  • 2. A retrospective single centre study of the outcome of five different therapy approaches in 48 patients with relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation.
    Elmaagacli AH, Beelen DW, Schaefer UW.
    Bone Marrow Transplant; 1997 Dec 01; 20(12):1045-55. PubMed ID: 9466277
    [Abstract] [Full Text] [Related]

  • 3. Recombinant alpha-interferon as treatment for chronic myelogenous leukemia in relapse after allogeneic bone marrow transplantation: a report from the Société Française de Greffe de Moelle.
    Pigneux A, Devergie A, Pochitaloff M, Rio B, Archimbaud E, Cahn JY, Leblond V, Michallet M, Jouet JP, Guilhot F.
    Bone Marrow Transplant; 1995 Jun 01; 15(6):819-24. PubMed ID: 7581075
    [Abstract] [Full Text] [Related]

  • 4. Estimations of BCR-ABL/ABL transcripts by quantitative PCR in chronic myeloid leukaemia after allogeneic bone marrow transplantation and donor lymphocyte infusion.
    Otazú IB, Tavares Rde C, Hassan R, Zalcberg I, Tabak DG, Seuánez HN.
    Leuk Res; 2002 Feb 01; 26(2):129-41. PubMed ID: 11755463
    [Abstract] [Full Text] [Related]

  • 5. Quantification of BCR-ABL transcripts in CML patients in cytogenetic remission after interferon-alpha-based therapy.
    Martinelli G, Testoni N, Amabile M, Bonifazi F, De Vivo A, Farabegoli P, Terragna C, Montefusco V, Ottaviani E, Saglio G, Russo D, Baccarani M, Rosti G, Tura S.
    Bone Marrow Transplant; 2000 Apr 01; 25(7):729-36. PubMed ID: 10745258
    [Abstract] [Full Text] [Related]

  • 6. Molecular monitoring of response to imatinib (Glivec) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission.
    Paschka P, Müller MC, Merx K, Kreil S, Schoch C, Lahaye T, Weisser A, Petzold A, König H, Berger U, Gschaidmeier H, Hehlmann R, Hochhaus A.
    Leukemia; 2003 Sep 01; 17(9):1687-94. PubMed ID: 12970765
    [Abstract] [Full Text] [Related]

  • 7. A special fluorescent in situ hybridization technique to study peripheral blood and assess the effectiveness of interferon therapy in chronic myeloid leukemia.
    Buño I, Wyatt WA, Zinsmeister AR, Dietz-Band J, Silver RT, Dewald GW.
    Blood; 1998 Oct 01; 92(7):2315-21. PubMed ID: 9746769
    [Abstract] [Full Text] [Related]

  • 8. Use of alpha interferon for the treatment of relapse of chronic myelogenous leukemia in chronic phase after allogeneic bone marrow transplantation.
    Higano CS, Raskind WH, Singer JW.
    Blood; 1992 Sep 15; 80(6):1437-42. PubMed ID: 1520870
    [Abstract] [Full Text] [Related]

  • 9. Prolonged subcutaneous administration of recombinant alpha 2b interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase chronic myelogenous leukemia: effect on remission duration and survival: Cancer and Leukemia Group B study 8583.
    Ozer H, George SL, Schiffer CA, Rao K, Rao PN, Wurster-Hill DH, Arthur DD, Powell B, Gottlieb A, Peterson BA, Rai K, Testa JR, LeBeau M, Tantravahi R, Bloomfield CD.
    Blood; 1993 Nov 15; 82(10):2975-84. PubMed ID: 8219189
    [Abstract] [Full Text] [Related]

  • 10. Use of interferon alfa-2a to treat hematologic relapse of chronic myelogenous leukemia after bone marrow transplantation.
    Higano CS, Raskind WH, Singer JW.
    Acta Haematol; 1993 Nov 15; 89 Suppl 1():8-14. PubMed ID: 8475671
    [Abstract] [Full Text] [Related]

  • 11. Persistence of dormant leukemic progenitors during interferon-induced remission in chronic myelogenous leukemia. Analysis by polymerase chain reaction of individual colonies.
    Talpaz M, Estrov Z, Kantarjian H, Ku S, Foteh A, Kurzrock R.
    J Clin Invest; 1994 Oct 15; 94(4):1383-9. PubMed ID: 7929813
    [Abstract] [Full Text] [Related]

  • 12. Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon alpha.
    Merx K, Müller MC, Kreil S, Lahaye T, Paschka P, Schoch C, Weisser A, Kuhn C, Berger U, Gschaidmeier H, Hehlmann R, Hochhaus A.
    Leukemia; 2002 Sep 15; 16(9):1579-83. PubMed ID: 12200666
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Conversion of interferon-induced, long-term cytogenetic remissions in chronic myelogenous leukemia to polymerase chain reaction negativity.
    Kurzrock R, Estrov Z, Kantarjian H, Talpaz M.
    J Clin Oncol; 1998 Apr 15; 16(4):1526-31. PubMed ID: 9552062
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Interferon-alpha 2a therapy in CML: disappearance of BCR/ABL transcript in a case of long-lasting continuous cytogenetic conversion.
    Pardini S, Addis M, Dore F, Bonfigli S, Nieddu RM, Galanello R, Longinotti M, Pau MG.
    Haematologica; 1994 Apr 15; 79(6):540-1. PubMed ID: 7896213
    [Abstract] [Full Text] [Related]

  • 18. Case report of spontaneous remission of cytogenetic relapse of chronic myelogenous leukemia suggestive of progression to blast crisis after allogeneic bone marrow transplantation.
    Agaliotis DP, Papenhausen PR, Moscinski LC, Elfenbein GJ.
    Ann Hematol; 1995 Jan 15; 70(1):37-41. PubMed ID: 7827205
    [Abstract] [Full Text] [Related]

  • 19. Persistence of BCR/ABL mRNA-expressing bone-marrow cells in patients with chronic myelogenous leukemia in complete cytogenetic remission induced by interferon-alpha therapy.
    Eberlé F, Toiron Y, Camerlo J, Lafage M, Sainty D, Arnoulet C, Raineri V, Gabert J, Maraninchi D, Mannoni P.
    Leuk Lymphoma; 1995 Jun 15; 18(1-2):153-7. PubMed ID: 8580818
    [Abstract] [Full Text] [Related]

  • 20. [Treatment with interferon alfa-2a in the chronic phase of Philadelphia-positive chronic myeloid leukemia].
    Steegmann JL, Lavilla E, Somolinos N, Pérez-Sánchez M, Lamana M, Olmeda F, Cámara R, Arranz R, Ferro MT, Fernández-Rañada JM.
    Sangre (Barc); 1992 Oct 15; 37(5):375-81. PubMed ID: 1293778
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.